Ruland S - Search Results

1

Ruland S, Gorelick PB. Ruland S, et al. Curr Cardiol Rep. 2005 Jan;7(1):29-33. doi: 10.1007/s11886-005-0007-5. Curr Cardiol Rep. 2005. PMID: 15610644 Review.

2

Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?

Ruland S, Gorelick PB. Ruland S, et al. Curr Neurol Neurosci Rep. 2003 Jan;3(1):21-6. doi: 10.1007/s11910-003-0032-y. Curr Neurol Neurosci Rep. 2003. PMID: 12507406 Review.

3

Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?

Ruland S, Gorelick PB. Ruland S, et al. Curr Atheroscler Rep. 2003 Jan;5(1):38-43. doi: 10.1007/s11883-003-0067-1. Curr Atheroscler Rep. 2003. PMID: 12562541 Review.

4

Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial.

Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, Kittner S, Leurgans S; African American Antiplatelet Stroke Prevention Study Investigators. Gorelick PB, et al. Among authors: ruland s. JAMA. 2003 Jun 11;289(22):2947-57. doi: 10.1001/jama.289.22.2947. JAMA. 2003. PMID: 12799402 Clinical Trial.

5

Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS.

Ruland S, Hung E, Richardson D, Misra S, Gorelick PB; African American Antiplatelet Stroke Prevention Study Investigators. Ruland S, et al. Arch Neurol. 2005 Mar;62(3):386-90. doi: 10.1001/archneur.62.3.386. Arch Neurol. 2005. PMID: 15767503

6

Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities.

Ruland S, Gorelick PB, Schneck M, Kim D, Moore CG, Leurgans S. Ruland S, et al. Stroke. 2002 May;33(5):1334-9. doi: 10.1161/01.str.0000014609.44258.ad. Stroke. 2002. PMID: 11988612

7

IMAGES and FAST-MAG: magnesium for acute ischaemic stroke.

Gorelick PB, Ruland S. Gorelick PB, et al. Among authors: ruland s. Lancet Neurol. 2004 Jun;3(6):330. doi: 10.1016/S1474-4422(04)00762-8. Lancet Neurol. 2004. PMID: 15157845 Review. No abstract available.

8

Cerebral vascular disease.

Gorelick PB, Ruland S. Gorelick PB, et al. Among authors: ruland s. Dis Mon. 2010 Feb;56(2):39-100. doi: 10.1016/j.disamonth.2009.12.003. Dis Mon. 2010. PMID: 20141768 Review. No abstract available.

9

Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design.

Amin-Hanjani S, Rose-Finnell L, Richardson D, Ruland S, Pandey D, Thulborn KR, Liebeskind DS, Zipfel GJ, Elkind MS, Kramer J, Silver FL, Kasner SE, Caplan LR, Derdeyn CP, Gorelick PB, Charbel FT; VERiTAS Study Group. Amin-Hanjani S, et al. Among authors: ruland s. Int J Stroke. 2010 Dec;5(6):499-505. doi: 10.1111/j.1747-4949.2010.00528.x. Int J Stroke. 2010. PMID: 21050408 Free PMC article.

10

Optimized Hemodynamic Assessment to Predict Stroke Risk in Vertebrobasilar Disease: Analysis From the VERiTAS Study.

See AP, Pandey DK, Du X, Rose-Finnell L, Charbel FT, Derdeyn CP, Amin-Hanjani S; VERiTAS Study Group* †. See AP, et al. J Am Heart Assoc. 2020 Jun 16;9(12):e016406. doi: 10.1161/JAHA.120.016406. Epub 2020 Jun 5. J Am Heart Assoc. 2020. PMID: 32500810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters